Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice

Authors:

Abstract
Cyclohexyl-griselimycin is a preclinical candidate for use against tuberculosis (TB). Here, we show that this oral cyclodepsipeptide is also active against the intrinsically drug-resistant nontuberculous mycobacterium Mycobacterium abscessus in vitro and in a mouse model of infection.
Funding Information
  • HHS | National Institutes of Health (R01AI132374)

This publication has 24 references indexed in Scilit: